Cargando…
Review of the Effectiveness of Various Adjuvant Therapies in Treating Mycobacterium tuberculosis
Tuberculosis disease is caused by the bacterium Mycobacterium tuberculosis. It is estimated that 10 million people have developed tuberculosis disease globally, leading to 1.4 million deaths in 2019. Treatment of tuberculosis has been especially challenging due to the rise of multidrug-resistant (MD...
Autores principales: | Amin, Arman, Vartanian, Artin, Yegiazaryan, Aram, Al-Kassir, Abdul Latif, Venketaraman, Vishwanath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482146/ https://www.ncbi.nlm.nih.gov/pubmed/34562999 http://dx.doi.org/10.3390/idr13030074 |
Ejemplares similares
-
Root Causes of Fungal Coinfections in COVID-19 Infected Patients
por: Amin, Arman, et al.
Publicado: (2021) -
General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus
por: To, Kimberly, et al.
Publicado: (2020) -
Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially Mycobacterium tuberculosis
por: Ferlita, Steve, et al.
Publicado: (2019) -
Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
por: Mundra, Akaash, et al.
Publicado: (2023) -
Mycobacterium tuberculosis
por: Venketaraman, Vishwanath, et al.
Publicado: (2015)